Clinical evaluation of commercial automated SARS-CoV-2 immunoassays

OBJECTIVE: Numerous immunoassays for detecting antibodies directed against SARS-CoV-2 have been rapidly developed and released. Validations of these have been performed with a limited number of samples. The lack of standardisation might lead to significantly different results. This study compared te...

Descripción completa

Detalles Bibliográficos
Autores principales: Kittel, Maximilian, Muth, Maria Christina, Zahn, Ingrid, Roth, Heinz-Jürgen, Thiaucourt, Margot, Gerhards, Catharina, Haselmann, Verena, Neumaier, Michael, Findeisen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725057/
https://www.ncbi.nlm.nih.gov/pubmed/33310108
http://dx.doi.org/10.1016/j.ijid.2020.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725057/
https://www.ncbi.nlm.nih.gov/pubmed/33310108
http://dx.doi.org/10.1016/j.ijid.2020.12.003

Ejemplares similares